Physician profile
Michael A Wilson
NPI 1255340337
$522.60
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2022: $13.89 · 2024: $18.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $128.81 | 2019-2024 | |
| Amgen INC. | $58.63 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.63 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.21 | 2019 | |
| Pfizer INC. | $33.32 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.14 | 2019 | |
| Horizon Therapeutics Plc | $23.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.69 | 2019 | |
| Astellas Pharma US INC | $18.25 | 2019 | |
| Zyla Life Sciences, INC. | $17.90 | 2019 | |
| Radius Health, INC. | $17.62 | 2019 | |
| Shire North American Group INC | $15.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2019 | |
| Lilly USA, LLC | $13.77 | 2019 | |
| Glaxosmithkline, LLC. | $13.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $12.22 | 2019 | |
| Merck Sharp & Dohme LLC | $11.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.